Biosynex Cash Flow-to-Debt Ratio
Biosynex cash flow-to-debt ratio. Biosynex (ALBIO) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2025, meaning its operating cash flow of €-7.07 Million could theoretically repay 0% of its total liabilities (€105.13 Million) in one year. Check Biosynex (ALBIO) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biosynex (2008–2024)
Cash flow-to-debt ratio of Biosynex from 2008 to 2024. Historical debt coverage capacity for Biosynex across 12 annual periods. Check total reinvestment intensity of Biosynex to assess the company's total reinvestment commitment from operating cash flow.
Biosynex Cash Flow-to-Debt Ratio by Year (2008–2024)
Biosynex cash flow-to-debt ratio by year from 2008 to 2024. Year-by-year debt coverage analysis for Biosynex. For the full cash flow conversion analysis, see ALBIO operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.09x | €-10.12 Million | €114.19 Million | ▼ -7.8% |
| 2023 | -0.08x | €-9.65 Million | €117.41 Million | ▼ -255.0% |
| 2022 | 0.05x | €4.95 Million | €93.21 Million | ▼ -95.1% |
| 2021 | 1.09x | €109.83 Million | €101.14 Million | ▲ +105.2% |
| 2020 | 0.53x | €31.64 Million | €59.78 Million | ▲ +713.2% |
| 2019 | 0.07x | €1.10 Million | €16.97 Million | ▲ +42.1% |
| 2018 | 0.05x | €467.12K | €10.20 Million | ▲ +9.6% |
| 2017 | 0.04x | €484.82K | €11.60 Million | ▲ +29.2% |
| 2016 | 0.03x | €489.91K | €15.15 Million | ▼ -52.2% |
| 2015 | 0.07x | €461.66K | €6.82 Million | ▼ -9.7% |
| 2009 | 0.07x | €72.40K | €965.95K | ▲ +129.7% |
| 2008 | -0.25x | €-184.44K | €731.01K | — |